What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey-Reference-Cited by-同舟云学术

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

Published:2020-12-10 Issue:1 Volume:7 Page:00807-2020
ISSN:2312-0541
Container-title:ERJ Open Research
language:en
Short-container-title:ERJ Open Res

Author:

Shteinberg Michal^ORCID,Boyd Jeanette,Aliberti Stefano^ORCID,Polverino Eva,Harris Bridget,Berg Tove,Posthumus Annette,Ruddy Thomas,Goeminne Pieter,Lloyd Ernie,Alan Timothy,Altenburg Josje,Crossley Barbara,Blasi Francesco^ORCID,Chalmers James

Funder

European Respiratory Society

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference16 articles.

1. BTS guideline for oxygen use in adults in healthcare and emergency settings

2. Abate G , Stapleton JT , Rouphael N , et al. Variability in the management of adults with pulmonary nontuberculous mycobacterial disease. Clin Infect Dis 2020; in press [https://doi.org/10.1093/cid/ciaa252].doi:10.1093/cid/ciaa252].

3. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases

4. Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014;El-Zeenni;Eur J Clin Microbiol Infect Dis,2018

5. Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Practices for the Management of Patients with Non-Tuberculous Mycobacterial Pulmonary Disease According to a German Nationwide Analysis of Expert Centers;Healthcare;2023-09-22

2. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease;International Journal of Antimicrobial Agents;2023-07

3. Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration;European Respiratory Journal;2023-06

4. Global survey of physician testing practices for nontuberculous mycobacteria;ERJ Open Research;2023-03-30

5. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery;Respiratory Research;2022-12-24